Results 31 to 40 of about 4,100,045 (206)

Forest plot of the comparison between SSYX combined with anti-arrhythmia drugs plus routine treatment and anti-arrhythmia drugs plus routine treatment for the outcome Pwd.

open access: yes, 2016
Forest plot of the comparison between SSYX combined with anti-arrhythmia drugs plus routine treatment and anti-arrhythmia drugs plus routine treatment for the outcome Pwd.
Zhaoling Li (1454944)   +6 more
core   +1 more source

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity

open access: yesBMC Pulmonary Medicine, 2022
Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use.
Wang Chun Kwok   +4 more
doaj   +1 more source

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine

open access: yesRoyal Society Open Science, 2021
Hydroxychloroquine (HCQ), the hydroxyl derivative of chloroquine (CQ), is widely used in the treatment of rheumatological conditions (systemic lupus erythematosus, rheumatoid arthritis) and is being studied for the treatment and prevention of COVID-19 ...
Dominic G. Whittaker   +7 more
doaj   +1 more source

Case Report: Nadolol–mexiletine combination therapy for refractory neonatal long QT syndrome: a case series beyond sodium channelopathies

open access: yesFrontiers in Pediatrics
Neonatal long QT syndrome (LQTS) is associated with substantial mortality and poses significant therapeutic challenges, particularly in cases refractory to beta-blocker monotherapy.
Jihye You, Jihye You, Hyun Ho Kim
doaj   +1 more source

Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

open access: yesFrontiers in Physiology, 2017
Anti-arrhythmic drugs are a mainstay in the management of symptoms related to arrhythmias, and are adjuncts in prevention and treatment of life-threatening ventricular arrhythmias.
Jem D. Lane, Jem D. Lane, Andrew Tinker
doaj   +1 more source

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report

open access: yesFrontiers in Cardiovascular Medicine, 2023
Myocarditis is challenging to diagnose because of its various clinical manifestations. Fulminant myocarditis (FM) is a severe type of myocarditis characterized by heart failure, malignant arrhythmia, cardiogenic shock, and cardiac arrest.
Chi Zhou
doaj   +1 more source

Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical Rheumatologists

open access: yesFrontiers in Medicine, 2022
Juvenile dermatomyositis (JDM) is a common form of inflammatory myositis in children. Vasculopathy and endothelial dysfunction play significant roles in the pathogenesis of JDM.
Sanjib Mondal   +2 more
doaj   +1 more source

Anti-Cancer Agents in Medicinal Chemistry

open access: yes
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Letizia polito
core   +3 more sources

Cardioprotective effects of Ferulic acid against various drugs and toxic agents

open access: yesBeni-Suef University Journal of Basic and Applied Sciences, 2022
Background Homeostatic regulation of cardiomyocytes is indispensable in maintaining the normal physiological activity of cardiac tissue. Cardiotoxicity induced by drugs may lead to cardiac abnormalities such as arrhythmia, myocardial infarction and ...
Anandakumar Pandi   +3 more
doaj   +1 more source

Arrhythmia Classification Based on Combined Chaotic and Statistical Feature Extraction [PDF]

open access: yes, 2018
Obvious information content in Electro cardio graph has become mandatory to reveal the abnormalities in the heart functions. Arrhythmia is commonly seen heart disorder and results in fatal end, if not identified and treated properly within time limits ...
S, Pushpa   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy